2-(4-acetylphenyl)-1H-benzo[d]imidazole-4-carboxamide | 936551-54-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: 2-(4-acetylphenyl)-1H-benzo[d]imidazole-4-carboxamide
• 英文别名: 2-(4-acetylphenyl)-1H-benzimidazole-4-carboxamide
• CAS: 936551-54-1
• 化学式: C₁₆H₁₃N₃O₂
• 分子量: 279.298
• InChiKey: RYRFKJHJQBMMJL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  88.8
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(4-acetylphenyl)-1H-benzo[d]imidazole-4-carboxamide 在 N-溴代丁二酰亚胺(NBS) 、 过氧化苯甲酰 作用下， 以 三氟乙酸 为溶剂， 反应 7.0h， 以35%的产率得到2-(4-(2-bromoacetyl)phenyl)-1H-benzo[d]imidazole-4-carboxamide
  参考文献：
  名称：

  Synthesis and Evaluation of a New Generation of Orally Efficacious Benzimidazole-Based Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors as Anticancer Agents

  摘要：

  Small molecule inhibitors of PARP-1 have been pursued by various organizations as potential therapeutic agents either capable of sensitizing cytotoxic treatments or acting as stand-alone agents to combat cancer. As one of the strategies to expand our portfolio of PARP-1 inhibitors, we pursued unsaturated heterocycles to replace the saturated cyclic alpine derivatives appended to the benzimidazole core. Not only did a variety of these new generation compounds maintain high enzymatic potency, many of them also displayed robust cellular activity. For example, the enzymatic IC50 and cellular EC50 values were as low as 1 nM or below. Compounds 24 (EC50 = 3.7 nM) and 44 (EC50 = 7.8 nM), featuring an oxadiazole and a pyridine moiety, respectively, demonstrated balanced potency and PK profiles. In addition, these two molecules exhibited potent oral in vivo efficacy in potentiating the cytotoxic agent temozolomide in a B16F10 murine melanoma model.

  DOI：

  10.1021/jm900697r
• 作为产物：
  描述：

  3-[(4-Acetylbenzoyl)amino]-2-aminobenzamide 在 sodium hydroxide 、 溶剂黄146 作用下， 以 水 为溶剂， 反应 11.5h， 生成 2-(4-acetylphenyl)-1H-benzo[d]imidazole-4-carboxamide
  参考文献：
  名称：

  SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS

  摘要：

  化合物的化学式(I)抑制PARP酶，可用于治疗与PARP相关的疾病或疾病。还披露了包含化合物的药物组合物的化学式(I)，包含化合物的治疗方法的方法的化学式(I)，以及包含化合物的PARP酶抑制方法的方法的化学式(I)。

  公开号：

  US20070112047A1

文献信息

• SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS
  申请人：Giranda Vincent L.

  公开号：US20070259937A1

  公开（公告）日：2007-11-08

  The present invention relates to 1H-benzimidazole-4-carboxamides of formula (I), their preparation, and their use as inhibitors of the enzyme poly(ADP-ribose)polymerase for the preparation of drugs.

  本发明涉及式(I)的1H-苯并咪唑-4-甲酰胺、其制备以及作为聚(ADP-核糖)聚合酶的抑制剂以制备药物的用途。
• Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
  申请人：——

  公开号：US07999117B2

  公开（公告）日：2011-08-16

  The present invention relates to 1H-benzimidazole-4-carboxamides of formula (I), their preparation, and their use as inhibitors of the enzyme poly(ADP-ribose)polymerase for the preparation of drugs.

  本发明涉及公式（I）的1H-苯并咪唑-4-羧酰胺，它们的制备以及它们作为聚（ADP核糖）聚合酶酶的抑制剂用于制备药物的用途。
• US7462724B2
  申请人：——

  公开号：US7462724B2

  公开（公告）日：2008-12-09
• US7595406B2
  申请人：——

  公开号：US7595406B2

  公开（公告）日：2009-09-29
• US7999117B2
  申请人：——

  公开号：US7999117B2

  公开（公告）日：2011-08-16